TipRanks
JW LIFESCIENCE CORPORATION (KR:234080)
:234080
South Korea Market
234080
JW LIFESCIENCE CORPORATION
RESEARCH TOOLSreports

JW LIFESCIENCE CORPORATION (234080) Ratios

― Followers

JW LIFESCIENCE CORPORATION Ratios

KR:234080's free cash flow for Q2 2026 was ₩0.27. For the 2026 fiscal year, KR:234080's free cash flow was decreased by ₩ and operating cash flow was ₩0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.25 1.05 1.32 1.14 1.31
Quick Ratio
 0.81 0.67 0.88 0.90 1.04
Cash Ratio
 0.14 0.10 0.09 0.21 0.05
Solvency Ratio
 0.56 0.48 0.48 0.45 0.27
Operating Cash Flow Ratio
 0.73 0.48 0.63 0.40 0.18
Short-Term Operating Cash Flow Coverage
 1.55 0.83 1.42 0.82 0.38
Net Current Asset Value
₩ 2.98B₩ -9.34B₩ -19.21B₩ 11.39B₩ -7.60B
Leverage Ratios
Debt-to-Assets Ratio
 0.11 0.16 0.21 0.18 0.27
Debt-to-Equity Ratio
 0.14 0.23 0.35 0.29 0.48
Debt-to-Capital Ratio
 0.12 0.19 0.26 0.23 0.32
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.14 <0.01 0.18
Financial Leverage Ratio
 1.35 1.44 1.62 1.61 1.80
Debt Service Coverage Ratio
 1.42 0.93 1.63 0.93 0.95
Interest Coverage Ratio
 23.41 11.74 17.40 11.46 8.76
Debt to Market Cap
 0.18 0.25 0.40 0.23 0.36
Interest Debt Per Share
 2.13K 3.46K 4.60K 3.16K 4.54K
Net Debt to EBITDA
 0.45 0.82 0.80 0.51 1.45
Profitability Margins
Gross Profit Margin
27.45%27.06%25.85%25.31%25.47%
EBIT Margin
13.14%12.92%27.46%17.08%15.24%
EBITDA Margin
20.42%19.94%34.53%24.57%23.14%
Operating Profit Margin
13.14%12.92%16.12%14.92%14.34%
Pretax Profit Margin
12.61%12.31%26.53%16.30%11.00%
Net Profit Margin
10.26%11.09%19.77%13.61%7.92%
Continuous Operations Profit Margin
10.26%11.09%19.77%13.61%7.92%
Net Income Per EBT
81.34%90.11%74.52%83.49%71.99%
EBT Per EBIT
95.95%95.32%164.61%109.22%76.72%
Return on Assets (ROA)
8.51%8.99%13.52%11.00%5.91%
Return on Equity (ROE)
11.81%12.97%21.94%17.66%10.66%
Return on Capital Employed (ROCE)
13.87%14.25%14.63%19.10%15.67%
Return on Invested Capital (ROIC)
10.00%10.60%9.50%12.41%9.28%
Return on Tangible Assets
11.35%11.86%17.77%11.18%6.02%
Earnings Yield
14.88%14.41%26.11%14.13%8.12%
Efficiency Ratios
Receivables Turnover
 6.25 5.76 3.77 3.73 3.54
Payables Turnover
 9.95 11.13 8.41 8.24 9.31
Inventory Turnover
 6.32 5.95 4.65 6.60 6.38
Fixed Asset Turnover
 2.04 2.00 1.68 1.66 1.44
Asset Turnover
 0.83 0.81 0.68 0.81 0.75
Working Capital Turnover Ratio
 21.55 17.57 11.39 10.74 68.79
Cash Conversion Cycle
 79.51 91.99 131.92 108.94 121.19
Days of Sales Outstanding
 58.45 63.41 96.89 97.94 103.18
Days of Inventory Outstanding
 57.76 61.38 78.43 55.28 57.20
Days of Payables Outstanding
 36.70 32.80 43.40 44.27 39.19
Operating Cycle
 116.21 124.79 175.32 153.21 160.38
Cash Flow Ratios
Operating Cash Flow Per Share
 3.03K 2.62K 3.27K 2.43K 912.42
Free Cash Flow Per Share
 2.24K 1.81K 2.61K 1.89K 376.83
CapEx Per Share
 786.81 812.72 665.59 533.87 535.58
Free Cash Flow to Operating Cash Flow
 0.74 0.69 0.80 0.78 0.41
Dividend Paid and CapEx Coverage Ratio
 2.29 2.00 2.81 2.35 0.88
Capital Expenditure Coverage Ratio
 3.85 3.23 4.92 4.55 1.70
Operating Cash Flow Coverage Ratio
 1.48 0.80 0.73 0.81 0.21
Operating Cash Flow to Sales Ratio
 0.19 0.16 0.23 0.18 0.07
Free Cash Flow Yield
20.77%14.10%23.97%14.72%3.17%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.57 6.96 3.83 7.08 12.32
Price-to-Sales (P/S) Ratio
 0.67 0.77 0.76 0.96 0.98
Price-to-Book (P/B) Ratio
 0.77 0.90 0.84 1.25 1.31
Price-to-Free Cash Flow (P/FCF) Ratio
 4.81 7.09 4.17 6.79 31.58
Price-to-Operating Cash Flow Ratio
 3.64 4.90 3.32 5.30 13.04
Price-to-Earnings Growth (PEG) Ratio
 -0.14 -0.20 0.07 0.08 0.74
Price-to-Fair Value
 0.77 0.90 0.84 1.25 1.31
Enterprise Value Multiple
 3.75 4.68 3.00 4.43 5.66
Enterprise Value
 194.31B 240.69B 230.20B 225.23B 247.55B
EV to EBITDA
 3.75 4.68 3.00 4.43 5.66
EV to Sales
 0.77 0.93 1.03 1.09 1.31
EV to Free Cash Flow
 5.47 8.60 5.70 7.69 42.42
EV to Operating Cash Flow
 4.05 5.94 4.54 5.99 17.52
Tangible Book Value Per Share
 9.49K 9.29K 7.92K 10.03K 8.77K
Shareholders’ Equity Per Share
 14.32K 14.28K 12.94K 10.29K 9.06K
Tax and Other Ratios
Effective Tax Rate
 0.19 0.10 0.25 0.17 0.28
Revenue Per Share
 16.02K 16.69K 14.37K 13.36K 12.20K
Net Income Per Share
 1.64K 1.85K 2.84K 1.82K 966.18
Tax Burden
 0.81 0.90 0.75 0.83 0.72
Interest Burden
 0.96 0.95 0.97 0.95 0.72
Research & Development to Revenue
 0.02 0.02 0.02 0.02 0.03
SG&A to Revenue
 0.09 0.07 0.05 0.07 0.05
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.84 1.42 1.15 1.34 0.94
Currency in KRW